Literature DB >> 17259656

The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium.

Margot M Ip1, Sibel O McGee, Patricia A Masso-Welch, Clement Ip, Xiaojing Meng, Lihui Ou, Suzanne F Shoemaker.   

Abstract

Conjugated linoleic acid (CLA), a family of isomers of octadecadienoic acid, inhibits rat mammary carcinogenesis, angiogenesis, and lung metastasis from a transplantable mammary tumor. c9,t11-CLA, the predominant isomer in dairy products, and t10,c12-CLA, a component of CLA supplements, are equally effective. The objective of the current studies was to test the efficacy of these two CLA isomers in a clinically relevant breast cancer model. Transgenic mice over-expressing erbB2 in the mammary epithelium were fed control or 0.5% CLA-supplemented diets continuously from weaning. Unexpectedly, t10,c12-CLA stimulated lobular hyperplasia of the mammary epithelium and accelerated mammary tumor development, decreasing median tumor latency to 168 days of age compared with 256 and 270 days in the c9,t11-CLA and control groups, respectively. Metastasis was also increased by t10,c12-CLA, with percentage of tumor-bearing mice with lung metastasis 73, 14 and 31% in the t10,c12-CLA, c9,t11-CLA and control groups, respectively. A second study, in which CLA administration was initiated after puberty, confirmed the stimulatory effect of t10,c12-CLA on mammary tumor development and metastasis. Additionally, t10,c12-CLA, but not c9,t11-CLA, increased the size of the liver, heart, spleen and mammary lymph node. The effects of t10,c12-CLA were not specific to erbB2 transgenic mice, as t10,c12-CLA supplementation increased proliferation in the mammary epithelium of both wild-type FVB and FVB/erbB2 mice. Moreover, the number of terminal end buds, the mammary epithelial structures most sensitive to a carcinogenic insult, was increased 30-fold in FVB wild-type mice fed t10,c12-CLA. These data suggest that it would be prudent to avoid CLA supplements containing the t10,c12-CLA isomer. However, even though c9,t11-CLA was not efficacious in the erbB2 model, its ability to inhibit mammary tumor development in rat models suggests that it may have activity for prevention of some types of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259656      PMCID: PMC2776704          DOI: 10.1093/carcin/bgm018

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  48 in total

1.  Safety profile of conjugated linoleic acid in a 12-month trial in obese humans.

Authors:  L D Whigham; M O'Shea; I C M Mohede; H P Walaski; R L Atkinson
Journal:  Food Chem Toxicol       Date:  2004-10       Impact factor: 6.023

Review 2.  Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature.

Authors:  Antonius H M Terpstra
Journal:  Am J Clin Nutr       Date:  2004-03       Impact factor: 7.045

3.  Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans.

Authors:  Jean-Michel Gaullier; Johan Halse; Kjetil Høye; Knut Kristiansen; Hans Fagertun; Hogne Vik; Ola Gudmundsen
Journal:  J Nutr       Date:  2005-04       Impact factor: 4.798

4.  Immunoglobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid.

Authors:  Masao Yamasaki; Hitomi Chujo; Akira Hirao; Nami Koyanagi; Takeaki Okamoto; Naomi Tojo; Ayana Oishi; Toshio Iwata; Yoshie Yamauchi-Sato; Takaya Yamamoto; Kentaro Tsutsumi; Hirofumi Tachibana; Koji Yamada
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

5.  Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.

Authors:  Fiona Moloney; Toh-Peng Yeow; Anne Mullen; John J Nolan; Helen M Roche
Journal:  Am J Clin Nutr       Date:  2004-10       Impact factor: 7.045

6.  Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.

Authors:  MaLinda D Henry; Aleata A Triplett; Keon Bong Oh; Gilbert H Smith; Kay-Uwe Wagner
Journal:  Oncogene       Date:  2004-09-09       Impact factor: 9.867

Review 7.  Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies.

Authors:  Thomas M Larsen; Soren Toubro; Arne Astrup
Journal:  J Lipid Res       Date:  2003-08-16       Impact factor: 5.922

8.  Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature.

Authors:  Patricia A Masso-Welch; Danilo Zangani; Clement Ip; Mary M Vaughan; Suzanne F Shoemaker; Sibel Oflazoglu McGee; Margot M Ip
Journal:  J Nutr       Date:  2004-02       Impact factor: 4.798

9.  Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans.

Authors:  Jean-Michel Gaullier; Johan Halse; Kjetil Høye; Knut Kristiansen; Hans Fagertun; Hogne Vik; Ola Gudmundsen
Journal:  Am J Clin Nutr       Date:  2004-06       Impact factor: 7.045

Review 10.  Prevention of mammary cancer with conjugated linoleic acid: role of the stroma and the epithelium.

Authors:  Margot M Ip; Patricia A Masso-Welch; Clement Ip
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

View more
  22 in total

1.  Conjugated linoleic acid induces apoptosis of murine mammary tumor cells via Bcl-2 loss.

Authors:  Lihui Ou; Clement Ip; Barbara Lisafeld; Margot M Ip
Journal:  Biochem Biophys Res Commun       Date:  2007-03-26       Impact factor: 3.575

2.  Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.

Authors:  Christina Donnelly; Arne M Olsen; Lionel D Lewis; Burton L Eisenberg; Alan Eastman; William B Kinlaw
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

3.  Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice.

Authors:  Margaret Flowers; Joyce A Schroeder; Alexander D Borowsky; David G Besselsen; Cynthia A Thomson; Ritu Pandey; Patricia A Thompson
Journal:  Carcinogenesis       Date:  2010-07-11       Impact factor: 4.944

4.  Trans-Fatty Acid-Stimulated Mammary Gland Growth in Ovariectomized Mice is Fatty Acid Type and Isomer Specific.

Authors:  Grace E Berryhill; Susan G Miszewski; Josephine F Trott; Jana Kraft; Adam L Lock; Russell C Hovey
Journal:  Lipids       Date:  2017-01-10       Impact factor: 1.880

5.  Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling.

Authors:  Robert A Ramirez; Amy Lee; Pepper Schedin; Joshua S Russell; Patricia A Masso-Welch
Journal:  Dev Dyn       Date:  2012-05       Impact factor: 3.780

6.  A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.

Authors:  Margit M McGowan; Burton L Eisenberg; Lionel D Lewis; Heather M Froehlich; Wendy A Wells; Alan Eastman; Nancy B Kuemmerle; Kari M Rosenkrantz; Richard J Barth; Gary N Schwartz; Zhongze Li; Tor D Tosteson; Bernard B Beaulieu; William B Kinlaw
Journal:  Breast Cancer Res Treat       Date:  2013-02-16       Impact factor: 4.872

7.  Conjugated linoleic acid-induced apoptosis in mouse mammary tumor cells is mediated by both G protein coupled receptor-dependent activation of the AMP-activated protein kinase pathway and by oxidative stress.

Authors:  Yung-Chung Hsu; Margot M Ip
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

8.  Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells.

Authors:  Yung-Chung Hsu; Xiaojing Meng; Lihui Ou; Margot M Ip
Journal:  Cell Signal       Date:  2009-11-20       Impact factor: 4.315

9.  t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways.

Authors:  Xiaojing Meng; Suzanne F Shoemaker; Sibel O McGee; Margot M Ip
Journal:  Carcinogenesis       Date:  2008-03-13       Impact factor: 4.944

10.  Diet-induced metabolic change induces estrogen-independent allometric mammary growth.

Authors:  Grace E Berryhill; Julia M Gloviczki; Josephine F Trott; Lucila Aimo; Jana Kraft; Robert D Cardiff; Carly T Paul; Whitney K Petrie; Adam L Lock; Russell C Hovey
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.